Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04284540 · ClinicalTrials.gov registry record · NA
Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT04284540 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 37 participants.
The verdict
NCT04284540, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate a shorter radiation treatment schedule for head and neck cancers in patients 70 years of age and older. Standard radiation treatment for head and neck patients normally requires that the patient travel to the hospital daily for 6-7 weeks to receive radiation treatment 5 days per week. This long course of radiation can lead to significant side effects resulting in some people being unable to complete the course of treatment. If this happens, and there are gaps in the radiation treatment, this can lead to worse outcomes.
Interventions
- RADIATION Adjuvant hypofractionation
- RADIATION Definitive Hypofractionation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2025-06-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04284540
The ClinicalTrials.gov registry entry for NCT04284540 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adjuvant hypofractionation is the first listed.
NCT04284540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04284540 about?
NCT04284540 is a clinical study titled "Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma". The purpose of this research study is to investigate a shorter radiation treatment schedule for head and neck cancers in patients 70 years of age and older. Standard radiation treatment for head and neck patients normally requires that the patient travel to the hospital daily for 6-7 weeks to recei...
What is the current status of trial NCT04284540?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2019-07-01. Estimated completion is 2025-06-12.
What interventions are being tested in trial NCT04284540?
The interventions under investigation include: Adjuvant hypofractionation (RADIATION), Definitive Hypofractionation (RADIATION).
Who is sponsoring clinical trial NCT04284540?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.